Lucinda V. Scott

Neuroscience · Life Sciences

31h-index5.1kcitations56works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Stress Responses and Cortisol(28), Tryptophan and brain disorders(18), Fibromyalgia and Chronic Fatigue Syndrome Research(13), Treatment of Major Depression(7), Neuroendocrine regulation and behavior(6)

Publications56 total

Relations Among Prenatal Subjective Stress, Weight Status, and Physiological Stress Markers
Scholar Works (Boise State University)·2021Open Access
Moderated Mediation of Infant in Utero Cortisol Exposure, Temperament, Breastfeeding and Sleep
Scholar Works (Boise State University)·2019
Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy
Journal of Psychiatric Research·2018· 50 citedOpen Access
Towards an understanding of depression-associated gut microbiota induced neurobehavioural changes in the rat
European Neuropsychopharmacology·2016· 12 cited
MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c
Translational Psychiatry·2016· 142 citedOpen Access
Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat
Journal of Psychiatric Research·2016· 1.6k citedOpen Access
PS193. MicroRNAs as biomarkers for treatment-resistant depression
The International Journal of Neuropsychopharmacology·2016Open Access
P.4.001 Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat
European Neuropsychopharmacology·2016· 10 cited
Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT
Journal of Affective Disorders·2015· 132 cited
P.2.b.032 Serum brain-derived neurotrophic factor and symptom improvements post-ketamine treatment in treatment-resistant depression
European Neuropsychopharmacology·2014
P.2.f.015 Biomarkers of the rapid clinical response to ketamine in treatment-resistant depression: focus on kynurenine
European Neuropsychopharmacology·2014
P.2.b.038 The cortisol awakening response in treatment-resistant depression is not a biomarker of the clinical response to ketamine
European Neuropsychopharmacology·2014· 1 cited
Corticotropin-releasing hormone and the hypothalamic–pituitary–adrenal axis in psychiatric disease
Handbook of clinical neurology·2014· 94 cited
The Brain-Gut Axis: A Target for Treating Stress-Related Disorders
Modern trends in psychiatry·2013· 46 cited
Enhanced Cholinergic-Mediated Increase in the Pro-Inflammatory Cytokine IL-6 in Irritable Bowel Syndrome: Role of Muscarinic Receptors
The American Journal of Gastroenterology·2008· 135 cited
S.15.02 HPA axis, glucocorticoids and depression: therapeutic possibilities
European Neuropsychopharmacology·2007
Impact of Gender and Menstrual Cycle Phase on Plasma Cytokine Concentrations
NeuroImmunoModulation·2007· 100 cited
Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy
Journal of Psychiatric Research·2006· 347 cited
Antidepressant therapy and C-reactive protein levels
The British Journal of Psychiatry·2006· 148 citedOpen Access
Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients
Journal of Affective Disorders·2006· 283 cited
page 1 of 3Next →

Frequent Co-authors

Timothy G. Dinan(45), Gerard Clarke(9), Sami Medbak(7), John F. Cryan(6), Sinead M. O’Brien(6), Karen A. Scott(4), Gerard M. Moloney(4), Paul Scully(4), M. Naughton(4), Joshua L. Dowling(4), Annabel Walsh(4), George Shorten(4), P. W. N. Keeling(4), Ena Lavelle(4), Frances Burnett(4), Jogin H. Thakore(4), John R. Kelly(3), Yuliya Borre(3), Elaine Patterson(3), Sahar El Aidy(3)